Biotech Archives - Page 136 of 795

5 minute read

Vertex Provides Pipeline And Business Updates In Advance Of 42nd Annual J.P. Morgan Healthcare Conference On Monday, January 8, 2024 At 11:15 a.m. ET/8:15 a.m. PT

January 7, 4:06 PM

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the company's scheduled webcast from the 42nd Annual J.P. Morgan

VRTX

3 minute read

Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai’s $50M And More

By Lara Goldstein

January 7, 1:36 PM

Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury

ATAI

2 minute read

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD

By Maureen Meehan

January 6, 4:59 PM

A decade after it was founded as a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), MAPS Pub

ATAI

2 minute read

Cannabis Significantly Improves Symptoms For Most Cancer Survivors, Confirms New Study

By Joana Scopel

January 5, 5:15 PM

A newly published study in the Journal of Cancer Survivorship has shown the prevalence and motivations behind cannabis use among individuals who have battled cancer.

TLLTF

2 minute read

Strides Toward Lower Drug Costs: Florida Becomes First To Receive Nod To Import Prescription Drugs from Canada

By Vandana Singh

January 5, 3:53 PM

The FDA has allowed Florida to import prescription drugs from Canada, potentially altering the landscape of how Americans access and afford their medications.

AZN

2 minute read

Cell Therapy Focused Allogene Therapeutics’ Resource Prioritization A Bold Move, Says Analyst

By Vandana Singh

January 5, 3:32 PM

Allogene Therapeutics Inc (NASDAQ: ALLO) announced deprioritizing the currently enrolling third line Phase 2 ALPHA2 and EXPAND trials of cema-cel (ALLO-501A) and is now pursuing a potentially pivotal trial (ALPHA3) evaluating cema-cel as a consolidation therapy in large B-cell lymphoma (LBCL) patients

ALLO